Search

Record Type Journal Article Author/Creator van Dijk, Erik

1. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT). (June 2022)

Authors:
Stroes, Charlotte I; Schokker, Sandor; Khurshed, Mohammed; van der Woude, Stephanie O; Mathôt, Ron AA; Slingerland, Marije; de Vos-Geelen, Judith; Zucchetti, Massimo; Matteo, Cristina; van Dijk, Erik; Ylstra, Bauke; Thijssen, Victor; Derks, Sarah; Godefa, Tesfay; Dijksterhuis, Willemieke; Breimer...
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatment. (July 2020)

Authors:
Beagan, Jamie J.; Bach, Sander; van Boerdonk, Robert A.; van Dijk, Erik; Thunnissen, Erik; van den Broek, Daan; Weiss, Janneke; Kazemier, Geert; Pegtel, D Michiel; Bahce, Idris; Ylstra, Bauke; Heideman, Daniëlle A.M.
Journal:
Lung cancer
Issue:
Volume 145(2020)
Page Start:
173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma. Issue 9 (15th July 2021)

Authors:
Drees, Esther E. E.; Roemer, Margaretha G. M.; Groenewegen, Nils J.; Perez‐Boza, Jennifer; van Eijndhoven, Monique A. J.; Prins, Leah I.; Verkuijlen, Sandra A. W. M.; Tran, Xuan‐Mai; Driessen, Julia; Zwezerijnen, G. J. C.; Stathi, Phylicia; Mol, Kevin; Karregat, Joey J. J. P.; Kalantidou, Aikater...
Journal:
Journal of extracellular vesicles
Issue:
Volume 10:Issue 9(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment. Issue 4 (5th April 2023)

Authors:
Stevens, Wendy B. C.; Los-de Vries, G. Tjitske; Langois-Jacques, Carole; Clear, Andrew J.; Stathi, Phylicia; Sander, Birgitta; Rosenwald, Andreas; Calaminici, Maria; Hoster, Eva; Hiddemann, Wolfgang; Gaulard, Philippe; Salles, Gilles; Klapper, Wolfram; Xerri, Luc; Burton, Catherine; Tooze, Reuben...
Journal:
HemaSphere
Issue:
Volume 7:Issue 4(2023)
Page Start:
e863
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX. Issue 7 (23rd May 2022)

Authors:
van Dijk, Erik; van Werkhoven, Erik; Asher, Rebecca; Mooi, Jennifer K.; Espinoza, David; van Essen, Hendrik F.; van Tinteren, Harm; van Grieken, Nicole C. T.; Punt, Cornelis J. A.; Tebbutt, Niall C.; Ylstra, Bauke
Journal:
International journal of cancer
Issue:
Volume 151:Issue 7(2022)
Page Start:
1166
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗